![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif)
oral fludarabine phosphate An oral formulation of the phosphate salt of fludarabine, a synthetic purine nucleoside analogue antimetabolite with antineoplastic activity. Fudarabine is preferentially transported into malignant cells and metabolized by deoxycytidine kinase to its active form, 2-fluoro-ara-ATP; 2-fluoro-ara-ATP competes directly with deoxyadenosine triphosphate (dATP) and inhibits alpha DNA polymerase, RNA reductase, and DNA primase, which may result in inhibition of DNA synthesis and cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif)
Foreign brand name: | ![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif) | Fludara Oral | | ![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif) | Code name: | ![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif) | SH T 586 | | ![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081025033540im_/http://www.cancer.gov/images/spacer.gif) |